Navigation Links
Cellectricon Launches World's First System for High Throughput RNAi Screening
Date:3/27/2008

GOTHENBERG, Sweden, March 27 /PRNewswire/ -- Cellectricon, a leading provider of screening solutions for drug discovery, today announced the launch of the new Cellaxess(R)HT System. The world's first fully automated high throughput transfection system enables reagent-free delivery of genetic material to a wide range of biologically relevant cell types. The system will be introduced at the SBS 14th Annual Conference and Meeting in St. Louis, MO, USA, April 6-10.

Cellectricon has developed Cellaxess(R)HT in close collaboration with leading research groups to meet the increasing demand for a technology capable of genome-wide RNAi screening.

"We are very pleased to meet the industry's demand by bringing this state-of-the-art system to the market." says Dr. Mattias Karlsson, CEO of Cellectricon. "Cellaxess(R)HT will revolutionize target discovery by opening the door to using more biologically relevant cell types in genome-wide RNAi screening."

About the Cellaxess(R)HT system

Cellaxess(R)HT addresses the critical need for high throughput delivery of siRNA and cDNA to hard to transfect cells in several cell-based screening assays. Cellaxess(R)HT is the only fully automated system on the market allowing for high throughput transfection of cells in culture directly in 384-well microplates. The system enables reagent-free delivery to a wide range of biologically relevant cell types with excellent efficiency and viability at a throughput of 50 000 wells per day.

About Cellectricon

Cellectricon is a key innovator and solutions provider of advanced cell-based screening products to accelerate biotechnology and drug discovery. The company's successfully launched products are aimed at critical bottlenecks in the drug discovery process and have been adopted by top-reference customers including the top ten pharmaceutical companies. To date, the company has launched two products with exceptional market acceptance targeting the ion chann
'/>"/>

SOURCE Cellectricon AB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
2. UPMC Health Plan Launches New Personal Health Record
3. HealthInsuranceFinders.com Launches Video Contest for Young Directors
4. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
5. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. Mannatech Launches Phase One of New Sales and Training Tools
8. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
9. Actavis Launches Carvedilol Tablets in the U.S.
10. MedQuist Re-launches New, Improved Web Site
11. Elsevier launches new journal: Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 2Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 3Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 4Health News:InfoZoom Launches V6.4 of its Industry Leading In-Memory Data Analysis Software 2Health News:InfoZoom Launches V6.4 of its Industry Leading In-Memory Data Analysis Software 3Health News:Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies 2Health News:Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies 3Health News:REES Announces New Baltimore Office 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 3Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 4Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 5Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 6
Breaking Medicine Technology:Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 37 Proven Steps 3A How to Defeat Stress Without Going Through the Embarrassment of Counseling 3A Proven Ways to Defeat Stress 49176 17 Proven Steps 3A How to Defeat Stress Without Going Through the Embarrassment of Counseling 3A Proven Ways to Defeat Stress 49176 27 Proven Steps 3A How to Defeat Stress Without Going Through the Embarrassment of Counseling 3A Proven Ways to Defeat Stress 49176 3iMedica Selected by NJ Physicians as Preferred EHR Vendor 49173 1iMedica Selected by NJ Physicians as Preferred EHR Vendor 49173 2Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 1Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 2Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 3Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 4Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 5Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 6Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 7Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 8Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 9Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 10